Sagimet Biosciences Inc. (SGMT) — Stock Score Summary

Sagimet Biosciences Inc. (SGMT) has a MoatMap StockRank of 27/100 based on Quality (41/100), Value (29/100), and Momentum (44/100) factor scores. The current signal is SELL. Sagimet Biosciences is a clinical-stage biotech developing denifanstat for MASH. It is a binary clinical trial play that lacks the structural, high-utilization manufacturing moat of a CDMO.

Sagimet Biosciences Inc. is a clinical-stage biotechnology company focused on developing novel therapeutics for metabolic diseases. The company's lead product candidate targets fatty acid synthase (FASN) for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). Sagimet operates in the highly competitive pharmaceutical industry, aiming to carve out a niche with its differentiated approach to fatty acid metabolism for liver disease and other conditions.

Key Financial Metrics

Price$6.58
Market Cap$449M
P/E (Forward)-5.38
Price/Book2.25
Return on Equity-36.0%
Return on Invested Capital-51.1%
Debt/Equity0.04
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-28M

Sagimet Biosciences Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Sagimet Biosciences Inc.’s (SGMT) StockRank?
MoatMap’s StockRank for Sagimet Biosciences Inc. (SGMT) is 27/100, with a Sell signal. It is a composite of Quality (41), Value (29), and Momentum (44) factor ranks across MoatMap’s 19,000+ stock universe.
Does Sagimet Biosciences Inc. have an economic moat?
Sagimet Biosciences Inc. (SGMT) has a Quality factor score of 41/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Sagimet Biosciences Inc. a buy, hold, or sell?
MoatMap’s current signal for Sagimet Biosciences Inc. (SGMT) is Sell, based on a StockRank of 27/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Sagimet Biosciences Inc. in?
Sagimet Biosciences Inc. (SGMT) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksSGMT deep dive reportAI ChampionsHow we score stocksSense-check another stock